QID 376977

QID 376977: Fortinet FortiManager and FortiAnalyzer - Inter ADOM Information Leakage Vulnerability (FG-IR-20-143)

An improper access control vulnerability [CWE-284] in FortiManager and FortiAnalyzer management interface may allow a remote and authenticated admin user assigned to a specific ADOM to access other ADOMs information such as device information and dashboard information.

Supported Affected Products:
FortiManager version 7.2.0
FortiManager version 7.0.0 through 7.0.3
FortiManager version 6.4.0 through 6.4.7
FortiManager version 6.2.0 through 6.2.9
FortiManager version 6.0.0 through 6.0.11
FortiAnalyzer version 7.2.0
FortiAnalyzer version 7.0.0 through 7.0.3
FortiAnalyzer version 6.4.0 through 6.4.8
FortiAnalyzer version 6.2.0 through 6.2.10
FortiAnalyzer version 6.0.0 through 6.0.12

QID Detection Logic(Authenticated):
QID will fire the command to get system status and will match the affected versions.

Vulnerable FortiManager and FortiAnalyzer management interface may allow a remote and authenticated admin user assigned to a specific ADOM to access other ADOMs information such as device information and dashboard information.

CVSS V3 rated as Medium - 4.3 severity.

CVSS V2 rated as Medium - 4 severity.

Solution

Customers are advised to refer to FG-IR-20-143 for more information.

Vendor References

FG-IR-20-143 - www.fortiguard.com/psirt/FG-IR-20-143

CVEs related to QID 376977

CVE-2022-38377 |

Software Advisories

Advisory ID	Software	Component	Link
FG-IR-20-143			www.fortiguard.com/psirt/FG-IR-20-143

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].